12. ROB table: sarilumab vs standard care(SC). Incidence of adverse events.
Study | 1.Randomisation | 2.Deviations from intervention | 3.Missing outcome data | 4.Measurement of the outcome | 5.Selection of the reported results | Overall risk of bias |
Lescure 2021 | Low | Low | Low | Low | Low | Low |